Literatur
Borrow R, Goldblatt D, Andrews N, Richmond P, Southern J, Miller E (2001) Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children. J Infect Dis 184: 377–380
Connolly M, Noah N (1999) Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993–6. Epidemiol Infect 122: 41–44
De Wals P, De Serres G, Niyonsenga T (2001) Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec. JAMA 285: 177–181
Heininger U (2001) Impfratgeber. UNI-MED Verlag, Bremen
Lieberman JM, Chiu SS, Wong VK, Partidge S, Chang SJ, Chiu CY, Gheesling LL, Carlone GM, Ward JI (1996) Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide- protein conjugate vaccine in young children. A randomized controlled trial. JAMA 275: 1499–1503
Peltola H, Makela H, Kayhty H, Jousimies H, Herva E, Hallstrom K, Sivonen A, Renkonen OV, Pettay O, Karanko V, Ahvonen P, Sarna S (1977) Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med 297: 686–691
Ramsay ME, Andrews N, Kaczmarski EB, Miller E (2001) Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357: 195–196
Robert Koch-Institut (1999) Ratgeber Infektionskrankheiten. 2. Folge: Meningokokken-Erkrankungen.Epidemiol Bull 11
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heininger, U. Prävention von invasiven Meningokokkeninfektionen. Monatsschr Kinderheilkd 150, 1005–1015 (2002). https://doi.org/10.1007/s00112-002-0519-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00112-002-0519-7